Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (21)

2023

  1. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration

    Hepatology, Vol. 77, Núm. 4, pp. 1095-1105

2021

  1. Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects

    Liver International, Vol. 41, Núm. 9, pp. 2076-2086

  2. Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data

    Gastroenterology, Vol. 160, Núm. 1, pp. 193-205.e10

2020

  1. International and multicenter real-world study of sorafenib-treated patients with hepatocellular carcinoma under dialysis

    Liver International, Vol. 40, Núm. 6, pp. 1467-1476

  2. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Journal of Hepatology, Vol. 73, Núm. 5, pp. 1082-1091

2019

  1. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH

    Gastroenterologia y Hepatologia, Vol. 42, Núm. 10, pp. 657-676

  2. Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study

    Hepatology, Vol. 69, Núm. 1, pp. 282-293

2014

  1. Rate of Detection of Advanced Neoplasms in Proximal Colon by Simulated Sigmoidoscopy vs Fecal Immunochemical Tests

    Clinical Gastroenterology and Hepatology, Vol. 12, Núm. 10, pp. 1708-1716.e4

2013

  1. Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study

    Hepatology, Vol. 58, Núm. 6, pp. 2079-2088

2010

  1. Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study

    Hepatology, Vol. 51, Núm. 1, pp. 210-218

2009

  1. Etiology, management, and outcome of the Budd-Chiari syndrome

    Annals of Internal Medicine, Vol. 151, Núm. 3, pp. 167-175

2008

  1. Extrahepatic portal vein thrombosis

    Seminars in Liver Disease, Vol. 28, Núm. 3, pp. 282-292

  2. Obstruction of the Portal Vein

    Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition (Blackwell Publishing Ltd), pp. 1395-1402

2006

  1. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension

    Hepatology, Vol. 43, Núm. 3, pp. 485-491

  2. Influence of beta-2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis

    Hepatology, Vol. 43, Núm. 1, pp. 34-41

  3. Pharmacological Reduction of Portal Pressure and Long-Term Risk of First Variceal Bleeding in Patients with Cirrhosis

    American Journal of Gastroenterology, Vol. 101, Núm. 3, pp. 506-512

  4. Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd-Chiari syndrome

    Hepatology, Vol. 43, Núm. 1, pp. 27-33

2005

  1. Increased hepatic resistance: A new target in the pharmacologic therapy of portal hypertension

    Journal of Clinical Gastroenterology, Vol. 39, Núm. 4 SUPPL.

  2. Portal hypertension secondary to myelofibrosis: A study of three cases

    American Journal of Gastroenterology, Vol. 100, Núm. 10, pp. 2355-2358

2004

  1. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome

    Hepatology, Vol. 40, Núm. 5, pp. 1197-1202